Published in Blood Weekly, September 24th, 2009
"In addition, Kupffer cells (KCs), normally thought to initiate immune responses, are rendered tolerogenic in this context. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-09-24)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.